PRESS RELEASE

Q1 2020 — Press release

Q1 2020PDF · 17 pages126 KB
April 28, 2020
3M Reports First-Quarter 2020 Results
First-Quarter Highlights:
Sales of $8.1 billion, up 2.7 percent year-on-year
Organic local-currency sales grew 0.3 percent year-on-year
GAAP EPS of $2.22; adjusted EPS of $2.16
Operating cash flow of $1.2 billion, up 16 percent year-on-year; adjusted free
cash flow of $0.9 billion, up 40 percent year-on-year
Withdraws full-year 2020 guidance due to COVID-19 impact and end-market
uncertainty
ST. PAUL, Minn.--(BUSINESS WIRE)-- 3M (NYSE: MMM) today reported first-quarter 2020
results.
“In this unprecedented time, I could not be more proud of how our 96,000 people have
stepped up to help fight COVID-19, and I thank all 3Mers for their incredible efforts,” said
Mike Roman, 3M chairman and chief executive officer. “We are attacking the pandemic from
all angles, which includes mobilizing all of our resources and rapidly increasing output of
critical supplies to healthcare workers and first responders.”
“Given the breadth and diversity of our businesses, the financial impact of COVID-19 is
varying across 3M,” Roman continued. “In the first quarter we saw strong growth in personal
safety, as well as in other areas of our portfolio experiencing high demand due to the
pandemic. At the same time, we experienced weak demand in several end markets that
were more severely impacted by actions taken around the world to slow the pandemic.
Looking ahead, 3M is taking action that will help us navigate near-term uncertainty, generate
strong cash flow, and lead out of the slowdown by delivering for employees, customers and
shareholders.”
COVID-19 Response & Business Impact
3M has been aggressively responding to the COVID-19 pandemic given its critical role as a
provider of personal protective equipment in the U.S. and across the world. Since the
beginning of the year, 3M has continued to:
Lead in pandemic response
Accelerated respirator production, including ramped up idle respirator lines
Doubled global respirator output to 100 million/month (U.S. ~35 million/month)
Increasing capital investment to double respirator output again
Partnering to create innovative solutions to protect healthcare workers
Prioritize supplies to the most critical areas
Immediately redirected vast majority of global respirators output to healthcare
Uniting with governments and distribution partners to expedite products to
healthcare workers
Closely collaborating with U.S. Administration, FDA, HHS, DoD and FEMA to

-- 1 of 17 --

import 166.5 million respirators into the U.S.
Fight fraud and price gouging
Working with distributors and governments to ensure secure supply chains
3M has not increased respirator prices as a result of the pandemic
Published N95 respirator prices; created hotline for fraud and price gouging
Working with national and local legal authorities to bring lawsuits in multiple
states and Canada
Support communities through aid for relief and recovery efforts
Contributing $20 million in financial support to frontline healthcare workers,
vulnerable populations disproportionately affected by the virus and medical
research initiatives
The COVID-19 pandemic is affecting 3M’s businesses in a number of ways. 3M has
experienced strong end-market demand, specifically in personal safety, home improvement,
general cleaning, food safety and biopharma filtration. At the same time, several other end
markets have experienced significant weakness due to social distancing and shelter-in-place
mandates. These end markets include oral care, automotive OEM and aftermarket, general
industrial, commercial solutions, and stationery and office.
The company is continuing to adapt quickly to the current environment, with a focus on
mitigating the near-term impact while positioning 3M’s businesses for success coming out of
the crisis. Actions being taken include:
Protecting our employees
Mobilized global crisis action team in January
Updated safe workplace protocols globally, including work-from-home where
possible
Implemented pandemic support programs
Ensuring business continuity
Maintaining strong customer service with new global Enterprise Operations
organization
Ongoing adjustments to operations, including targeted shutdowns due to weak
customer/market demand or government mandates
Targeted paid short-term furloughs in businesses most impacted
Protecting financial flexibility
Taking aggressive cost reductions while minimizing employee impact—estimated
cost savings of $350 to $400 million in the second quarter of 2020
Adjusting capital allocation plans—prioritizing organic investments and the
dividend, and suspended share repurchase program
Reduced full-year 2020 cap-ex plan to approximately $1.3 billion versus $1.6 to
$1.8 billion, previously
Added $1.75 billion of cash via March 2020 debt issuance
Continue to expect after-tax proceeds of $0.4 billion from closing of drug delivery
divestiture in second quarter 2020
Withdrawing Full-Year Outlook
Due to the evolving and uncertain impact of the COVID-19 pandemic, 3M currently is not
able to estimate the full duration, magnitude and pace of recovery across its diverse end
markets with reasonable accuracy. Therefore, 3M believes it is prudent to withdraw its

-- 2 of 17 --

previously communicated full-year 2020 outlook, which was provided on January 28, 2020.
The company will begin reporting monthly sales information starting in May to provide
transparency on 3M’s ongoing business performance.
First-Quarter Results
Sales were up 2.7 percent year-on-year to $8.1 billion. Organic local-currency sales grew
0.3 percent while acquisitions, net of divestitures, increased sales by 4.2 percent. Foreign
currency translation reduced sales by 1.8 percent year-on-year.
Total sales grew 21.0 percent in Health Care and 4.6 percent in Consumer, with declines of
1.0 percent in Safety and Industrial and 5.0 percent in Transportation and Electronics.
Organic local-currency sales increased 6.1 percent in Consumer, 2.2 percent in Safety and
Industrial and 1.2 percent in Health Care, with a decline of 3.0 percent in Transportation and
Electronics.
On a geographic basis, total sales grew 10.1 percent in the Americas, with declines of 2.1
percent in EMEA (Europe, Middle East and Africa) and 5.4 percent in Asia Pacific. Organic
local-currency sales increased 4.2 percent in the Americas, with declines of 1.7 percent in
EMEA and 4.4 percent in Asia Pacific.
First-quarter GAAP earnings were $2.22 per share, an increase of 47 percent year-on-year,
with operating income of $1.7 billion and operating margins of 20.6 percent.
Excluding special items, first-quarter adjusted earnings were $2.16 per share, a decline of
2.7 percent year-on-year, with operating income of $1.7 billion and operating margins of 20.8
percent, as referenced in the “Supplemental Financial Information Non-GAAP Measures”
section.
The company’s operating cash flow was $1.2 billion with adjusted free cash flow of $0.9
billion contributing to adjusted free cash flow conversion of 74 percent. See the
“Supplemental Financial Information Non-GAAP Measures” section for applicable
information.
The company paid $847 million in cash dividends to shareholders and repurchased $365
million of its own shares during the quarter.
First-Quarter Business Group Discussion
Safety and Industrial
Sales of $2.9 billion, down 1.0 percent in U.S. dollars. Organic local-currency sales
increased 2.2 percent, foreign currency translation decreased sales by 2.2 percent,
and divestitures decreased sales by 1.0 percent.
On an organic local-currency basis:
Sales increased in personal safety, roofing granules, and industrial adhesives
and tapes; sales declined in closure and masking, electrical markets, automotive
aftermarket, and abrasives.
Sales grew in the Americas and EMEA; sales declined in Asia Pacific.
Operating income was $726 million, an increase of 14.0 percent year-on-year;
operating margins of 24.7 percent.

-- 3 of 17 --

Transportation and Electronics
Sales of $2.2 billion, down 5.0 percent in U.S. dollars. Organic local-currency sales
decreased 3.0 percent, foreign currency translation decreased sales by 1.3 percent,
and divestitures decreased sales by 0.7 percent.
On an organic local-currency basis:
Sales increased in electronics and were flat in advanced materials, and
transportation safety; sales declined in commercial solutions, and automotive and
aerospace.
Sales declined in the Americas, Asia Pacific and EMEA.
Operating income was $484 million, a decline of 7.3 percent year-on-year; operating
margins of 21.6 percent.
Adjusted operating income was $482 million, a decline of 7.1 percent year-on-year;
adjusted operating margins of 21.5 percent.
Health Care
Sales of $2.1 billion, up 21.0 percent in U.S. dollars. Organic local-currency sales
increased 1.2 percent, foreign currency translation decreased sales by 1.8 percent,
and acquisitions increased sales by 21.6 percent.
On an organic local-currency basis:
Sales grew in drug delivery, food safety, medical solutions, and separation and
purification, and were flat in health information systems; sales declined in oral
care.
Sales grew in the Americas; sales declined in EMEA and Asia Pacific.
Both GAAP and adjusted operating income was $456 million, a decline of 1.7 percent
year-on-year on a GAAP basis; or a decline of 0.7 percent on an adjusted basis;
operating margins of 21.7 percent.
Consumer
Sales of $1.3 billion, up 4.6 percent in U.S. dollars. Organic local-currency sales
increased 6.1 percent and foreign currency translation decreased sales by 1.5 percent.
On an organic local-currency basis:
Sales grew in home improvement, home care and consumer health care; sales
declined in stationery and office supplies.
Sales grew in the Americas; sales declined in Asia Pacific and EMEA.
Operating income was $269 million, up 14.5 percent year-on-year; operating margins
of 21.4 percent.
3M will conduct an investor teleconference at 9:00 a.m. EDT (8:00 a.m. CDT) today.
Investors can access this conference via the following:
Live webcast at http://investors.3M.com.
Live telephone:
Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the
call at least 10 minutes before the start time.
Webcast replay:
Go to 3M’s Investor Relations website at http://investors.3M.com and click on
“Quarterly Earnings.”

-- 4 of 17 --

Telephone replay:
Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S.
and outside the U.S., the access code is 21930637). The telephone replay will be
available until 11:30 a.m. EDT (10:30 a.m. CDT) on May 5, 2020.
Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and
estimates and business prospects that involve substantial risks and uncertainties. You can
identify these statements by the use of words such as "anticipate," "estimate," "expect,"
"aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and
other words and terms of similar meaning in connection with any discussion of future
operating or financial performance or business plans or prospects. Among the factors that
could cause actual results to differ materially are the following: (1) worldwide economic,
political, regulatory, capital markets and other external conditions and other factors beyond
the Company's control, including natural and other disasters or climate change affecting the
operations of the Company or its customers and suppliers; (2) risks related to public health
crises such as the global pandemic associated with the coronavirus (COVID-19); (3)
liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-
related products and chemistries, and claims and governmental regulatory proceedings and
inquiries related to PFAS in a variety of jurisdictions; (4) legal proceedings, including
significant developments that could occur in the legal and regulatory proceedings described
in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2019, and any
subsequent quarterly reports on Form 10-Q (the “Reports”); (5) competitive conditions and
customer preferences; (6) foreign currency exchange rates and fluctuations in those rates;
(7) the timing and market acceptance of new product offerings; (8) the availability and cost of
purchased components, compounds, raw materials and energy (including oil and natural gas
and their derivatives) due to shortages, increased demand or supply interruptions (including
those caused by natural and other disasters and other events); (9) unanticipated problems or
delays with the phased implementation of a global enterprise resource planning (ERP)
system, or security breaches and other disruptions to the Company's information technology
infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other
unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including
scenarios where the Company generates fewer productivity improvements than estimated;
(12) financial market risks that may affect the Company’s funding obligations under defined
benefit pension and postretirement plans; and (13) the Company's credit ratings and its cost
of capital. Changes in such assumptions or factors could produce significantly different
results. A further description of these factors is located in the Reports under "Cautionary
Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items
1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as
updated by applicable Current Reports on Form 8-K. The information contained in this news
release is as of the date indicated. The Company assumes no obligation to update any
forward-looking statements contained in this news release as a result of new information or
future events or developments.
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME

-- 5 of 17 --

(Millions, except per-share amounts)
(Unaudited)
Three months
ended
March 31,
2020 	2019
Net sales 	$8,075 $7,863
Operating expenses
Cost of sales 	4,109 	4,310
Selling, general and administrative expenses 	1,768 	1,948
Research, development and related expenses 	537 	477
Gain on sale of businesses 	(2) 	(8)
Total operating expenses 	6,412 	6,727
Operating income 	1,663 	1,136
Other expense (income), net 	96 	48
Income before income taxes 	1,567 	1,088
Provision for income taxes 	273 	195
Net income including noncontrolling interest 	$1,294 $ 893
Less: Net income attributable to noncontrolling interest 	2 	2
Net income attributable to 3M 	$1,292 $ 891
Weighted average 3M common shares outstanding – basic 	576.8 	577.5
Earnings per share attributable to 3M common shareholders – basic 	$ 2.24 $ 1.54
Weighted average 3M common shares outstanding – diluted 	581.5 	588.5
Earnings per share attributable to 3M common shareholders – diluted 	$ 2.22 $ 1.51
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
March 31,
December
31,

-- 6 of 17 --

2020 	2019
ASSETS
Current assets
Cash and cash equivalents 	$ 	4,253 $ 	2,353
Marketable securities – current 	224 	98
Accounts receivable – net 	4,821 	4,791
Inventories 	4,217 	4,134
Prepaids 	604 	704
Other current assets 	971 	891
Total current assets 	15,090 	12,971
Property, plant and equipment – net 	9,165 	9,333
Operating lease right of use assets 	849 	858
Goodwill and intangible assets – net 	19,503 	19,823
Other assets 	1,605 	1,674
Total assets 	$ 46,212 $ 44,659
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and
current portion of long-term debt 	$ 	3,248 $ 	2,795
Accounts payable 	2,207 	2,228
Accrued payroll 	523 	702
Accrued income taxes 	136 	194
Operating lease liabilities – current 	244 	247
Other current liabilities 	2,776 	3,056
Total current liabilities 	9,134 	9,222
Long-term debt 	19,247 	17,518
Other liabilities 	7,622 	7,793
Total liabilities 	$ 36,003 $ 34,533
Total equity 	$ 10,209 $ 10,126
Shares outstanding
March 31, 2020: 575,196,371 shares
December 31, 2019: 575,184,835 shares
Total liabilities and equity 	$ 46,212 $ 44,659
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)

-- 7 of 17 --

Three months
ended
March 31,
2020 	2019
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 	$ 1,213 $ 1,048
Cash flows from investing activities:
Purchases of property, plant and equipment 	(332) 	(391)
Acquisitions, net of cash acquired 	(25) 	(704)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net 	(111) 	(142)
Proceeds from sale of businesses, net of cash sold 	86 	6
Other investing activities 	7 	6
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 	(375) (1,225)
Cash flows from financing activities:
Change in debt 	2,207 1,591
Purchases of treasury stock 	(365) 	(701)
Proceeds from issuances of treasury stock pursuant to stock option
and benefit plans 	149 	215
Dividends paid to shareholders 	(847) 	(830)
Other financing activities 	(36) 	(17)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 	1,108 	258
Effect of exchange rate changes on cash and cash equivalents 	(46) 	4
Net increase (decrease) in cash and cash equivalents 	1,900 	85
Cash and cash equivalents at beginning of year 	2,353 2,853
Cash and cash equivalents at end of period 	$ 4,253 $ 2,938
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)

-- 8 of 17 --

(Dollars in millions, except per share amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Q1 2019 GAAP 	$ 	1,136 	14.4 % $ 1,088 $ 	195
Adjustments for special items:
Significant litigation-related charges/benefits 	548 	548 	124
(Gain)/loss on sale of businesses 	(8) 	(8)
Q1 2019 adjusted amounts (non-GAAP
measures) (a) 	$ 	1,676 	21.3 % $ 1,628 $ 	318
Q1 2020 GAAP 	$ 	1,663 	20.6 % $ 1,567 $ 	273
Adjustments for special items:
Significant litigation-related charges/benefits 	17 	17
(Gain)/loss on sale of businesses 	(2) 	(2)
Q1 2020 adjusted amounts (non-GAAP
measures) (a) 	$ 	1,678 	20.8 % $ 1,582 $ 	326
Three months ended March 31, 2020
(dollars in millions)
Safety and
Industrial
Transportation
and Electronics Health Care Consumer
Operating income (measure of
segment operating performance) 	$ 726 	$ 	484 	$ 	456 	$ 269
Operating income margin 	24.7 % 	21.6 % 	21.7 % 	21.4
Adjustments for special items:
Significant litigation-related
charges/benefits
(Gain)/loss on sale of businesses 	$ 	(2)
Adjusted operating income (non-GAAP
measures) (a) 	$ 726 	$ 	482 	$ 	456 	$ 269
Adjusted operating income margin
(non-GAAP measures) (a) 	24.7 % 	21.5 % 	21.7 % 	21.4
Three months ended March 31, 2019
(dollars in millions)
Safety and
Industrial
Transportation
and Electronics Health Care Consumer
Operating income (measure of
segment operating performance) 	$ 637 	$ 	522 	$ 	464 	$ 235
Operating income margin 	21.5 % 	22.2 % 	26.7 % 	19.6
Adjustments for special items:

-- 9 of 17 --

Significant litigation-related
charges/benefits
(Gain)/loss on sale of businesses 	$ 	(3) 	$ 	(5)
Adjusted operating income (non-GAAP
measures) (a) 	$ 637 	$ 	519 	$ 	459 	$ 235
Adjusted operating income margin
(non-GAAP measures) (a) 	21.5 % 	22.1 % 	26.4 % 	19.6
(a) In addition to reporting financial results in accordance with U.S. GAAP, the Company
also provides non-GAAP measures that adjust for the special items. Special items for the
periods presented include the items described in the section entitled “Description of
Special Items”. Beginning in 2020, the Company includes gain/loss on sale of businesses
and divestiture-related restructuring actions as special items due to their potential
distortion of underlying operating results. Information provided herein reflects the impact
of this change for all periods presented. Operating income (measure of segment
operating performance), income before taxes, net income, earnings per share and
effective tax rate are all measures for which 3M provides the reported GAAP measure
and a measure adjusted for special items. The adjusted measures are not in accordance
with, nor are they a substitute for, GAAP measures. The Company considers these non-
GAAP measures in evaluating and managing the Company’s operations. The Company
believes that discussion of results adjusted for these items is meaningful to investors as
it provides a useful analysis of ongoing underlying operating trends. The determination of
these items may not be comparable to similarly titled measures used by other
companies.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Three months ended
March 31,
Major GAAP Cash Flow Categories (dollars in millions) 	2020 	2019
Net cash provided by (used in) operating activities 	$ 1,213 $ 1,048
Net cash provided by (used in) investing activities 	(375) 	(1,225)
Net cash provided by (used in) financing activities 	1,108 	258
Adjusted Free Cash Flow (non-GAAP measure) (dollars in
millions)
Net cash provided by (used in) operating activities 	$ 1,213 $ 1,048
Purchases of property, plant and equipment 	(332) 	(391)
Free cash flow 	$ 	881 $ 	657
Adjustments for special items:
Significant litigation-related after-tax payment impacts 	$ 	50 $ 	—

-- 10 of 17 --

Divestiture-related restructuring after-tax payment impacts 	— 	10
Adjusted free cash flow (b) 	$ 	931 $ 	667
Net income attributable to 3M 	$ 1,292 $ 	891
Adjustments for special items:
Significant litigation-related charges/benefits 	(39) 	424
(Gain)/loss on sale of businesses 	1 	(7)
Adjusted net income attributable to 3M (a)
$ 1,254 $ 1,308
Adjusted free cash flow conversion (b) 	74 % 	51 %
(b) Adjusted free cash flow and adjusted free cash flow conversion are not defined under
U.S. GAAP. Therefore, they should not be considered a substitute for income or cash
flow data prepared in accordance with U.S. GAAP and may not be comparable to
similarly titled measures used by other companies. The Company defines adjusted free
cash flow as net cash provided by operating activities, adjusted for special items, less
purchases of property, plant and equipment. Cash payments associated with special
items in the determination of adjusted free cash flow are reflected net of applicable tax
using the U.S. statutory corporate tax rate during the period of payment. It should not be
inferred that the entire adjusted free cash flow amount is available for discretionary
expenditures. The Company defines adjusted free cash flow conversion as adjusted free
cash flow divided by net income attributable to 3M, adjusted for special items. Special
items for the periods presented include the items described in section entitled
“Description of Special Items”. The Company believes adjusted free cash flow and
adjusted free cash flow conversion are meaningful to investors as they are useful
measures of performance, and the Company uses these measures as an indication of
the strength of the company and its ability to generate cash.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP me
Three months ended March 31, 	Three months ended March 31
(Dollars in
millions) 	2020 	2019 	2020
Safety and
Industrial 	$ 	825 	$ 	737 	28.1%
Transportation
and
Electronics 	559 	596 	25.0
Health Care 	584 	513 	27.8
Consumer 	285 	258 	22.7

-- 11 of 17 --

Corporate and
Unallocated 	(19) 	44
Elimination of
Dual Credit 	(116) 	(97)
Total
Company 	$ 	2,118 	$ 	2,051 	26.2%
Three months ended
Adjusted EBITDA (non-GAAP measure) (dollars in
millions) 	March 31, 2020 March 31, 2019
Net sales 	$ 	8,075 	$ 	7,863
Net income attributable to 3M 	1,292 	891
Add/(subtract):
Net (income)/loss attributable to noncontrolling
interest 	2 	2
Provision for income taxes 	273 	195
Other expense/(income):
Interest (Income)/expense 	113 	84
Pension & OPEB non-service cost (benefit) 	(17) 	(36)
Depreciation and amortization expense 	440 	375
Adjustments for special items:
Significant litigation-related charges/benefits 	17 	548
(Gain)/loss on sale of businesses 	(2) 	(8)
Adjusted EBITDA (c) 	$ 	2,118 	$ 	2,051
Adjusted EBITDA margin (c) 	26.2 % 	26.1 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA (non-GAAP measure)
Three months ended March 31, 2020 (dollars in millions)
Safety and
Industrial
Transportation
and
Electronics Health Care
Net sales 	$ 2,935 	$ 	2,238 	$
Operating income (measure of segment operating
performance) 	726 	484
Add/(subtract):
Depreciation and amortization 	99 	77

-- 12 of 17 --

Adjustments for special items:
Significant litigation-related charges/benefits
(Gain)/loss on sale of businesses 	(2)
Adjusted EBITDA (non-GAAP measure) (c) 	$ 825 	$ 	559 	$
Adjusted EBITDA margin (non-GAAP measure) (c) 	28.1 % 	25.0 %
Adjusted EBITDA (non-GAAP measure)
Three months ended March 31, 2019 (dollars in millions)
Safety and
Industrial
Transportation
and
Electronics Health Care
Net sales 	$ 2,963 	$ 	2,355 	$
Operating income (measure of segment operating
performance) 	637 	522
Add/(subtract):
Depreciation and amortization 	100 	77
Adjustments for special items:
Significant litigation-related charges/benefits
(Gain)/loss on sale of businesses 	(3)
Adjusted EBITDA (non-GAAP measure) (c) 	$ 737 	$ 	596 	$
Adjusted EBITDA margin (non-GAAP measure) (c) 	24.9 % 	25.3 %
(c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP.
Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a
substitute for other measures prepared in accordance with U.S. GAAP and may not be
comparable to similarly titled measures used by other companies. The Company defines
adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss)
attributable to noncontrolling interest, provision for income taxes, other
expense/(income), depreciation and amortization expense, and special items. For
business segments, the Company defines adjusted EBITDA as segment operating
income (3M’s measure of segment operating performance) adjusted for depreciation and
amortization expense and special items. The Company defines adjusted EBITDA margin
as adjusted EBITDA divided by net sales. Special items for the periods presented include
the items described in the section entitled “Description of Special Items”. The Company
considers these non-GAAP measures in evaluating and managing the Company’s
operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are
meaningful to investors as they provide useful analyses of ongoing underlying operating
trends.
March 31, December 31,
Net Debt (non-GAAP measure) 	2020 	2019

-- 13 of 17 --

Total debt 	$ 22,495 $ 	20,313
Less: Cash, cash equivalents and marketable securities 	4,511 	2,494
Net debt (d) 	$ 17,984 $ 	17,819
(d) Net debt is not defined under U.S. GAAP and may not be computed the same as
similarly titled measures used by other companies. The Company defines net debt as
total debt less the total of cash, cash equivalents and current and long-term marketable
securities. 3M believes net debt is meaningful to investors as 3M considers net debt and
its components to be an important indicator of liquidity and a guiding measure of capital
structure strategy.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also
provides various non-GAAP measures that incorporate adjustments for the impacts of
special items. Special items incorporated in the preparation of these non-GAAP measures
for the periods presented include the items described below:
Gain/loss from sale of businesses:
In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million after tax
loss) related to the sale of its advanced ballistic-protection business and recognition of
certain contingent consideration.
In the first quarter of 2019, 3M recorded a gain related to the sale of certain oral care
technology comprising a business in addition to reflecting an earnout on a previous
divestiture, which together resulted in a net gain of $8 million ($7 million after tax).
Divestiture-related restructuring actions:
In the first quarter of 2019, 3M made payments of approximately $13 million associated
with restructuring charges taken in 2018 related to addressing corporate functional
costs following the 2018 Communication Markets Division divestiture.
Significant litigation-related charges/benefits:
In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million
after tax) related to PFAS (certain perfluorinated compounds) matters. The charge was
more than offset by a reduction in tax expense of $52 million related to resolution of tax
treatment with authorities regarding the previously disclosed 2018 agreement reached
with the State of Minnesota that resolved the Natural Resources Damages (NRD)
lawsuit. These items, in aggregate, resulted in a $39 million after tax benefit. In the first
quarter of 2020, 3M made payments of approximately $63 million related to significant
litigation-related matters.
In the first quarter of 2019, 3M recorded significant litigation-related charges of $548

-- 14 of 17 --

million ($424 million after tax) related to historical PFAS manufacturing operations and
coal mine dust respirator mask lawsuits. In the first quarter of 2019, 3M made
immaterial payments related to significant litigation-related matters.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS (e)
(Unaudited)
Three months ended March 31, 2020
Europe,
Middle
Sales Change Analysis 	Asia- East and World-
By Geographic Area 	Americas Pacific Africa 	Wide
Volume – organic 	3.5% 	(3.9)% (2.8)% 	(0.1)%
Price 	0.7 	(0.5) 	1.1 	0.4
Organic local-currency sales 	4.2 	(4.4) 	(1.7) 	0.3
Acquisitions 	7.9 	0.9 	3.6 	4.8
Divestitures 	(0.7) 	(0.1) 	(1.2) 	(0.6)
Translation 	(1.3) 	(1.8) 	(2.8) 	(1.8)
Total sales change 	10.1% 	(5.4)% (2.1)% 	2.7%
Three months ended March 31, 2020
Worldwide Sales Change Organic local- 	Total sales
By Business Segment 	currency sales Acquisitions Divestitures Translation change
Safety and Industrial 	2.2 % 	— % 	(1.0)% 	(2.2)% 	(1.0)%
Transportation and
Electronics 	(3.0) 	— 	(0.7) 	(1.3) 	(5.0)
Health Care 	1.2 	21.6 	— 	(1.8) 	21.0
Consumer 	6.1 	— 	— 	(1.5) 	4.6
Total Company 	0.3 % 	4.8 % 	(0.6)% 	(1.8)% 	2.7%
(e) Total sales change is calculated based on reported sales results. The components of
sales change include organic local-currency sales, acquisitions, divestitures and
translation. Organic local-currency sales includes both organic volume impacts (which
excludes acquisition and divestiture impacts) and selling price changes. Acquisition and
divestiture impacts are measured separately for the first 12 months post-transaction.
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
Effective in the first quarter of 2020, in a continuing effort to improve the alignment of its

-- 15 of 17 --

businesses around customers and markets, the Company made the following changes:
Continued alignment of customer account activity
As part of 3M’s regular customer-focus initiatives, the Company realigned certain
customer account activity (“sales district”) to correlate with the primary divisional
product offerings in various countries and reduce complexity for customers when
interacting with multiple 3M businesses. This largely impacted the amount of dual
credit certain business segments receive as a result of sales district attribution. 3M
business segment reporting measures include dual credit to business segments for
certain sales and operating income. This dual credit is based on which business
segment provides customer account activity with respect to a particular product sold in
a specific country.
Additional actions impacting product line alignments
The remaining retail auto care product lines, formerly in the Automotive Aftermarket
Division (within the Safety and Industrial business segment), were realigned to the
Construction and Home Improvement Division (within the Consumer business
segment).
In addition, certain product lines were realigned within business segments. The
transdermal drug delivery components business, formerly included in the Drug Delivery
Systems Division, was realigned to the Medical Solutions Division (both of which are
within the Health Care business segment), and the paint protection film business,
formerly included in the Automotive and Aerospace Division, was realigned to the
Commercial Solutions Division (both of which are within the Transportation and
Electronics business segment).
The financial information presented herein reflects the impact of these changes for all
periods presented.
BUSINESS SEGMENT INFORMATION 	Three months ended
NET SALES 	March 31,
(Millions) 	2020 	2019
Safety and Industrial 	$ 2,935 $ 2,963
Transportation and Electronics 	2,238 	2,355
Health Care 	2,103 	1,738
Consumer 	1,256 	1,200
Corporate and Unallocated 	1 	22
Elimination of Dual Credit 	(458) 	(415)
Total Company 	$ 8,075 $ 7,863
BUSINESS SEGMENT INFORMATION 	Three months ended
OPERATING INCOME 	March 31,

-- 16 of 17 --

(Millions) 	2020 	2019
Safety and Industrial 	$ 	726 $ 	637
Transportation and Electronics 	484 	522
Health Care 	456 	464
Consumer 	269 	235
Corporate and Unallocated (f) 	(156) 	(625)
Elimination of Dual Credit 	(116) 	(97)
Total Company 	$ 1,663 $ 1,136
(f) Corporate and Unallocated operating income was impacted by significant litigation-
related charges in both 2020 and 2019 as indicated in the tables to which note (a)
relates.
About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in
sales, our 96,000 employees connect with customers all around the world. Learn more about
3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or
@3MNews.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200428005458/en/
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Tony Riter, 651-733-1141
or
Media Contact:
Fanna Haile-Selassie, 651-736-0876
Source: 3M

-- 17 of 17 --